Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1

Conditions

Anemia 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Colorectal Neoplasms 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6human papillomavirus vaccine, L1 type 16, 18 4Vaccines 3fluciclovine F-18 2pegylated granulocyte colony-stimulating factor 1halofantrine 1ferrous fumarate 1epoetin beta 1apatinib 1Tobacco Use Cessation Devices 1TachoSil 1Surveys and Questionnaires 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Patient Navigation 1Papillomavirus Vaccines 1Mindfulness 1Indocyanine Green 1Human Papillomavirus Recombinant Vaccine nonavalent 1Hepatitis B Vaccines 1Gonadal Steroid Hormones 1Gene Expression Profiling 1Engerix-B 1Early Intervention, Educational 1Counseling 1Cognitive Behavioral Therapy 1Cisplatin 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Uterine Cervical Neoplasms × ferrous fumarate × Clear all
NCT01953107 2021-05-12

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Sunnybrook Health Sciences Centre

Phase 4 Completed
200 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡